Header cover image
  • Investing Ideas
  • /
  • Canadian Pharmaceuticals & Biotech Undervalued based on future growth

Canadian Pharmaceuticals & Biotech Undervalued based on future growth

Results

2

1 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

2 companies

Medexus Pharmaceuticals

Market Cap: CA$89.4m

Operates as a pharmaceutical company in Canada and the United States.

MDP

CA$2.70

7D

5.9%

1Y

40.6%

Decibel Cannabis

Market Cap: CA$37.5m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

New

DB

CA$0.065

7D

8.3%

1Y

-50.0%